Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

ImmunoPrecise Antibodies (IPA) has entered a strategic partnership with Ribopro to transform therapeutic antibody discovery and development. The partnership will combine the mRNA [messenger ...

Ribopro focuses on the development and manufacture of mRNA and LNPs. Credit: Volha_R/Shutterstock. ImmunoPrecise Antibodies (IPA) has entered a strategic partnership with Ribopro to transform ...

This collaboration seeks to revolutionize the discovery and development of therapeutic antibodies by integrating RIBOPRO’s advanced mRNA-based antigen expression expertise with IPA’s in silico ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a global leader in AI-powered antibody discovery and development, today announced a strategic collaboration with RIBOPRO, a ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a global leader in AI-powered antibody discovery and development, today announced a strategic collaboration with RIBOPRO ...

AUSTIN, Texas, February 26, 2025--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a global leader in AI-powered antibody discovery and development, today ...

ImmunoPrecise Antibodies (IPA) announced a strategic collaboration with Ribopro. This collaboration seeks to revolutionize the discovery and development of therapeutic antibodies by integrating ...